Flowers Foods reports again today, but this is no clean-slate setup — the stock arrives at a second earnings event in eight days with shorts unmoved, analysts cutting targets, and the CEO's own selling on record.
The short position tells the most urgent story heading into today's print. At 15.7% of free float, FLO's short interest has barely budged since the May 14 earnings punished the stock by 7%. It has actually risen another 3.4% over the past week. The ORTEX short score holds at 70 — near the top of its tracked range — and days to cover remain close to seven. These are not bears covering into weakness. The 35%-plus expansion of the short book since mid-April is now the baseline, not a pre-event build. Borrow availability has tightened sharply this week, dropping from above 200% to 132% — still within normal range, but the fastest compression seen in months, and the cost to borrow has nearly doubled over the past month to 0.55%. The borrow market is not screaming squeeze, but it is tightening in a direction that bears need to watch.
Options positioning adds a second layer of caution. The put/call ratio is running above its 20-day average at 0.41, about 1.15 standard deviations elevated — a mild but real skew toward hedging that was absent before the May 14 print. Back then, the PCR sat well below its mean. The reversal in options sentiment, combined with a stock down 20% over the past month and 4% on the week to $7.01, paints a picture of investors bracing rather than speculating.
The analyst community has been moving in one direction only. Stephens cut its target from $11 to $8 on May 18 — four days ago — while maintaining Equal-Weight. Deutsche Bank had already taken its target to $7 in late March, precisely where the stock now trades. The mean target of $9.80 implies some upside from current levels, but the trajectory is unmistakably lower, with every recent revision a cut. Bears point to downward EPS revisions — consensus now models $1.05 for fiscal 2025 and only modest growth beyond that — alongside legal cost headwinds and customer destocking. Bulls lean on acquisitions like Dave's Killer Bread, manufacturer consolidation dynamics, and a valuation that has compressed to a P/E below 9 and a dividend yield approaching 12% at current prices. The EV/EBITDA factor score ranks in the 73rd percentile, suggesting the multiple has become genuinely cheap on an operating-cash basis.
One piece of context that does not flatter management: CEO Ryals McMullian sold $1.68 million of stock on April 1 at $8.03 — a price roughly 13% above where the stock closed yesterday. That transaction preceded both the May 14 miss and the further leg lower. Shorts who built at $8–9 hold that fact alongside the fundamental thesis. Today's print is less about whether the quarter can surprise and more about whether management can offer any credible narrative on volumes, pricing, and litigation costs that shifts the calculus for a short base that has already been proven right once.
See the live data behind this article on ORTEX.
Open FLO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
